Diskussionsleiter: V. Adams (Leipzig), I. Ott (München)
| (P734) | Regulation of EMMPRIN (CD147) on monocyte subsets in patients with acute myocardial infarction and aortic stenosis | |
| P. Seizer, H. Sturhan, S. v. Ungern Sternberg, D. Heinzmann, B. Bigalke, T. Geisler, M. Gawaz, A. May (Tübingen) | ||
| (P735) | Glycogen synthase kinase-3 interacts with and phosphorylates IKKγ/NEMO and is involved in the regulation of NF-κB activity | |
| S. Medunjanin, L. Schleithoff, S. Weinert, A. Schmeißer, R. Braun-Dullaeus (Magdeburg) | ||
| (P736) | Myeloperoxidase-deficiency protects from ventricular tachycardia in a murine model of ischemic cardiomyopathy | |
| M. Lange, M. Mollenhauer, A. Klinke, L. Remane, K. Friedrichs, T. K. Rudolph, S. Baldus, V. Rudolph (Köln) | ||
| (P737) | Myeloperoxidase promotes ventricular tachycardia upon myocardial ischemia and reperfusion | |
| K. Friedrichs, A. Klinke, V. Rudolph, L. Remane, M. Mollenhauer, J. Schneider, F. Deuschl, D. Lau, S. Baldus, T. K. Rudolph (Köln, Hamburg) | ||
| (P738) | The role of IKKα in atherosclerosis | |
| P. V. Tilstam, M. Gijbels, M. Habbeddine, C. Cudejko, Y. Asare, W. Theelen, B. Zhou, Y. Döring, M. Drechsler, L. Pawig, S. Simsekyilmaz, R. R. Koenen, M. de Winther, T. Lawrence, J. Bernhagen, A. Zernecke, C. Weber, H. Noels (Aachen, München; Maastricht, Amsterdam, NL; Marseille, FR) | ||
| (P739) | Plasma serotonin accumulation due to serotonin reuptake inhibitor administration alters leukocyte-endothelial interactions | |
| N. Herr, M. Mauler, T. Witsch, D. Stallmann, J. Mezger, S. Schmitt, C. Bode, D. Duerschmied (Freiburg im Breisgau) | ||
| (P740) | Methylene blue impairs epithelial and renal cell functions in an inflammatory environment | |
| I. Werner, N. Bogert, F. Guo, U. Stock, A. Moritz, A. Beiras-Fernandez (Frankfurt am Main) | ||
| (P741) | Polarization of macrophages modulates hypoxia-inducible factors | |
| D. M. Poitz, A. Augstein, F. Hantschke, S. Jellinghaus, M. Christoph, K. Ibrahim, R. H. Strasser (Dresden) | ||
| (P742) | Endotheliale Dysfunktion und gesteigerte Dehnbarkeit mesenterialer Widerstandsgefäße korrelieren mit schweren strukturellen Gefäßschäden bei GvHD als Modell einer systemischen Inflammation | |
| P. M. Schmid, A. Bouazzaoui, K. Doser, K. Schmid, P. Hoffmann, J. Schröder, G. Riegger, E. Holler, D. Endemann (Regensburg) | ||
| (P743) | Inflammasome regulation in monocyte subpopulations from patients with CAD as compared to healthy subjects | |
| A. Kratzer, N. Kränkel, M. F. Müller, G. Treichler, J. Manz, M. Riwanto, P. Jakob, P. Mocharla, H. Giral, T. Lüscher, U. Landmesser (Schlieren, Zürich, CH) | ||
| (P744) | Macrophage migration inhibitory factor in patients with ESRD | |
| C. Rammos, U. Hendgen-Cotta, R. Westenfeld, W. Kleophas, G. R. Hetzel, M. Kelm, T. Rassaf (Düsseldorf) | ||
| (P745) | TGF- β1 signaling contributes to VEGF resistance and monocyte dysfunction | |
| L.-M. Makowski, C. Adam, M. Leffers, J. Waltenberger, E. Pardali (Münster) | ||
| (P746) | Loss of Oligophrenin1 leads to uncontrolled Rho activation and increased thrombus formation in mice | |
| A. Fotinos, N. S. Gowert, P. Münzer, T. Schönberger, C. Klatt, S. Beck, O. Borst, P. Billuart, M. Schaller, F. Lang, M. Gawaz, M. Elvers (Tübingen, Düsseldorf; Paris, FR) |